相关实验视频
Updated: Jun 22, 2025
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
833
血纤维素素的损失有助于血小板过活性的小鼠有败血性休克
Shih-Yao Kao1, Cheng-Ming Tsao2, Hung-Yen Ke3
1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
Thrombosis research
|June 30, 2024
概括
纤维素素补充剂可以改善败血症中的血小板功能,解决出血和器官功能障碍等问题. 这项研究表明,纤维素原增强了血小板聚合,粘附和血块收缩在败血症大鼠.
科学领域:
- 生物医学科学 生物医学科学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 败血症会触发宿主反应的失调,导致器官功能障碍和凝血异常,如扩散性血管内凝血 (DIC).
- 败血症中的血小板功能障碍导致出血,二次感染和组织损伤,目前的血小板输血提供有限的益处.
- 纤维素素对血小板功能至关重要,但其在败血症引起的血小板功能障碍中的具体作用尚未完全理解.
研究的目的:
- 为了研究纤维素素对血小板过活性的影响,在性休克的老鼠模型中.
- 为了确定纤维素素补充剂是否可以在败血症期间恢复受损的血小板功能.
主要方法:
- 在雄性Wistar大鼠中,通过注射脂聚糖化物 (LPS) 和结和穿孔 (CLP) 手术诱导了败血症.
- 评估了血液动力学,生物化学和凝血参数.
- 血小板激活,聚合,粘附,扩散和纤维素凝块收缩使用各种测定方法测量,包括全血测定和聚合计.
主要成果:
- 患有LPS和CLP诱导的败血症的老鼠显示血纤维素水平显著降低,血小板聚合,粘附,扩散和凝块收缩受损.
- 纤维素素补充剂显著增强了败血症小鼠的血小板聚合.
- 用纤维素原剂也改善了血小板的粘附,扩散和血块收缩在败血症大鼠.
结论:
- 纤维素素补充剂显示出作为一种治疗策略来抵消血症中血小板过活性的承诺.
- 这种方法可以帮助管理与败血症和DIC相关的出血并发症.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
332
相关概念视频
01:22Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K
01:16Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
01:05Introduction to Hemostasis
7.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:18Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
01:09Coagulation
6.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.1K